SCHEMBL13952115

SCHEMBL13952115

COc1ccc2c(c1OC)C(=O)N(Cc1cccc3ccccc13)C2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.48
▸ RAB9A P51151 7/20 0.48
▸ TP53 P04637 3/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ HCRTR1 O43613 3/20 0.47
▸ HCRTR2 O43614 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ POLB P06746 2/20 0.46
▸ DRD2 P14416 1/20 0.46
▸ DRD4 P21917 1/20 0.46
▸ HTR7 P34969 1/20 0.46
▸ DRD3 P35462 1/20 0.46
▸ HTR2B P41595 1/20 0.46
▸ MAPT P10636 1/20 0.44
▸ NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4224826 0.84 NPC1 (0.52) NPC1RAB9ATP53SMN1; SMN2KDM4E
SCHEMBL4219635 0.82 NPC1 (0.50) NPC1RAB9ATP53SMN1; SMN2KDM4E
SCHEMBL13952304 0.81 NPC1 (0.54) NPC1RAB9ATP53SMN1; SMN2KDM4E
SCHEMBL4226433 0.80 NPC1 (0.48) NPC1RAB9ATP53SMN1; SMN2KDM4E
SCHEMBL4220059 0.80 NPC1 (0.48) NPC1RAB9ATP53SMN1; SMN2KDM4E
SCHEMBL4224669 0.78 NPC1 (0.53) NPC1RAB9ATP53SMN1; SMN2KDM4E
SCHEMBL4219512 0.77 NPC1 (0.52) NPC1RAB9ATP53SMN1; SMN2KDM4E
SCHEMBL4369528 0.77 GAA (0.54) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL13952099 0.76 NPC1 (0.49) NPC1RAB9ATP53SMN1; SMN2KDM4E
SCHEMBL13952097 0.76 PARP1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009026248-A2 HYDRAZIDE, AMIDE, PHTHALIMIDE AND PHTHALHYDRAZIDE ANALOGS AS INHIBITORS OF RETROVIRAL INTEGRASE THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH, OFFICE OF TECHNOLOGY TRANSFER (US) 2009-02-26 — — WO disclosed
Send feedback